Associate Professor of Medicine; Medical Director, Lung Transplant Program; Director, Adult Cystic Fibrosis Program
Pulmonology
Dr. Joseph M. Pilewski, MD
|
|
Give Review
Doctor Joseph M. Pilewski, MD is an expert in the field of Pulmonology. He attended University of Rochester School of Medicine and Dentistry. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Joseph Pilewski is a published doctor as well. He has 82 publications published. The latest was: Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Cystic fibrosis program directors' attitudes toward sexual and reproductive health in young women with CF.
- Effect of ivacaftor in patients with advanced Cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States.
- Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells.
- De novo donor-specific HLA antibodies are associated with early and high-grade Bronchiolitis obliterans syndrome and death after lung transplantation.
- Outcomes of intraoperative venoarterial extracorporeal membrane oxygenation versus cardioPulmonary bypass during lung transplantation.
- Highly Effective Cystic Fibrosis Clinical Research Teams: Critical Success Factors.
- Delayed chest closure after Lung transplantation: Techniques, outcomes, and strategies.
- Quantitative imaging of airway liquid absorption in Cystic fibrosis.
- E3 Ligase Subunit Fbxo15 and PINK1 Kinase Regulate Cardiolipin Synthase 1 Stability and Mitochondrial Function in Pneumonia.
- Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens.
- First successful lung transplantation for sickle cell disease with severe Pulmonary arterial hypertension and Pulmonary veno-occlusive disease.
- Plasma B lymphocyte stimulator and B cell differentiation in idiopathic Pulmonary fibrosis patients.
- Thrombospondin-1 triggers macrophage IL-10 production and promotes resolution of experimental Lung injury.
- Lobar Lung transplantation: a relevant surgical option in the current era of Lung allocation score.
- Clinical trials of health information technology interventions intended for patient use: Unique issues and considerations.
- Malignancies incidentally detected at Lung transplantation: radiologic and pathologic features.
- Nature and correlates of post-traumatic stress symptomatology in Lung transplant recipients.
- Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with Cystic fibrosis.
- Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in Lung draining lymph nodes.
- Early major neurologic complications after Lung transplantation: incidence, risk factors, and outcome.
- Multisite Comparison of Mucociliary and Cough Clearance Measures Using Standardized Methods.
- Liquid hyper-absorption as a cause of increased DTPA clearance in the Cystic fibrosis airway.
- Donor smoking history and age in Lung transplantation: a revisit.
- Idiopathic Pulmonary Fibrosis Patients With Antibodies to Heat Shock Protein 70 Have Poor Prognoses.
- Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in Fibrosis.
- Activated CD47 Promotes Pulmonary Arterial Hypertension Through Targeting Caveolin-1.
- Localized expression of tenascin in systemic sclerosis-associated Lung fibrosis and its regulation by IGF binding protein (IGFBP)-3.
- Extracorporeal Membrane Oxygenation as a Bridge to Lung Transplant: Midterm Outcomes.
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with Cystic fibrosis homozygous for the F508del-CFTR mutation.
- A polymorphism linked to elevated levels of interferon-γ is associated with an increased risk of cytomegalovirus disease among Caucasian Lung transplant re...
- Does simultaneous Lung-liver transplantation provide an immunologic advantage compared with isolated Lung transplantation?
- Five-year outcomes with alemtuzumab induction after Lung transplantation.
- Lung tissues in patients with systemic sclerosis have gene expression patterns unique to Pulmonary fibrosis and Pulmonary hypertension.
- Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy.
- High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination te...
- The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic Pulmonary fibrosis.
- IntraPulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients.
- Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking.
- Lung tissues in systemic sclerosis have gene expression patterns unique to Pulmonary fibrosis and Pulmonary hypertension.
- Effect of VX-770 in persons with Cystic fibrosis and the G551D-CFTR mutation.
- Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchoPulmonary aspergillosis.
- c-Cbl facilitates endocytosis and lysosomal degradation of Cystic fibrosis transmembrane conductance regulator in human airway epithelial cells.
- Exploring the meaning of Chronic rejection after lung transplantation and its impact on clinical management and caregiving.
- AMPK agonists ameliorate sodium and fluid transport and inflammation in Cystic fibrosis airway epithelial cells.
- Reduced histone deacetylase 7 activity restores function to misfolded CFTR in Cystic fibrosis.
- Role of insulin-like growth factor binding protein-3 in allergic airway remodeling.
- Experience with immune monitoring in Lung transplant recipients: correlation of low immune function with infection.
- SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia.
- Extracorporeal membrane oxygenation for primary graft dysfunction after Lung transplantation: long-term survival.
- Interleukin-17A induces bicarbonate secretion in normal human bronchial epithelial cells.
- Postdeposition dispersion of aerosol medications using surfactant carriers.
- CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the Lungs during cigarette smoke-induced emphysema.
- Chaperone displacement from mutant Cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia.
- Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in Lung transplant recipients.
- Prostasin expression is regulated by airway surface liquid volume and is increased in Cystic fibrosis.
- IL-22 mediates mucosal host defense against Gram-negative bacterial Pneumonia.
- Autoantibodies in patients with Chronic obstructive pulmonary disease.
- Defining an inhibitory domain in the alpha-subunit of the epithelial sodium channel.
- Egr-1 regulates autophagy in cigarette smoke-induced Chronic obstructive pulmonary disease.
- Cellular and humoral autoreactivity in idiopathic Pulmonary fibrosis.
- Successful outcome of human metapneumovirus (hMPV) pneumonia in a Lung transplant recipient treated with intravenous ribavirin.
- Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells.
- Molecular and functional properties of Lung SP cells.
- Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit.
- Insulin-like growth factor-binding protein-5 induces Pulmonary fibrosis and triggers mononuclear cellular infiltration.
- Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in Cystic fibrosis.
- Comprehensive analysis of gene expression on GOLD-2 Versus GOLD-0 smokers reveals novel genes important in the pathogenesis of COPD.
- The epithelial Na+ channel is inhibited by a peptide derived from proteolytic processing of its alpha subunit.
- Up-regulation of AMP-activated kinase by dysfunctional Cystic fibrosis transmembrane conductance regulator in Cystic fibrosis airway epithelial cells mitigates excessi...
- Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implicati...
- Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic Pulmonary fibrosis and contribute to extracellular matrix deposition.
- Comprehensive gene expression profiles reveal pathways related to the pathogenesis of Chronic obstructive pulmonary disease.
- Finally, mice with CF Lung disease.
- The status of gene therapy for Cystic fibrosis.
- Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model.
- Gene therapy for airway Diseases: continued progress toward identifying and overcoming barriers to efficiency.
- Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5.
- Autoreactivity to glucose regulated protein 78 links Emphysema and osteoporosis in smokers.
- A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in Cystic fibrosis.
- Pseudomonas infection and mucociliary and absorptive clearance in the cystic fibrosis Lung.
- Vitamin D supplementation decreases Aspergillus fumigatus specific Th2 responses in CF patients with aspergillus sensitization: a phase one open-label study.
Schools
University Of Rochester
Hospital Of The University Of Pennsylvania
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Atelectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
University of Rochester School of Medicine and Dentistry
Hospital
-
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1053386599 | |
| NPPES Provider LastName | PILEWSKI | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 152133403 | |
| NPPES Provider State | PA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 5141.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1053386599 |
| Last Name Of The Provider | PILEWSKI |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
|
Dr. Andrew Perez IV, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Shade Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel J. Givelber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad W. Butcher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fernando Holguin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan J. McVerry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rama K. Mallampalli, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Robert A. Peraino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher R. Brackney, DO |
|
|
Dr. Jerry D. Silverman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seema S. Tekwani, MD |
|
|
Marcy Zoller, CRNP
This Doctor is OpenDoctor Recommended.
|